Background: Inadequate or excessive GWG is associated with adverse maternal and neonatal outcomes. The 2009 revised Institute of Medicine (IOM) guidelines recommend GWG targets based on pre-pregnancy BMI. Women with pre-existing type 1 or 2 DM have distinct cardiometabolic risk profiles, making standard GWG recommendations potentially unsuitable for this population.
Aim: To assess whether pre-pregnancy BMI and GWG in women with pre-existing DM predicted maternal or neonatal outcomes.
Methods: This prospective cohort study enrolled pregnant individuals with pre-existing type 1 or 2 DM, aged over 18 years, who were seen in the Liverpool Hospital antenatal endocrine clinic. Baseline and follow-up data were collected from January 2019 to June 2025. Pregnancy loss <20 weeks and non-singleton pregnancies were excluded.
Results: 225 participants were included in final analysis, the mean age was 33.0 (±5.2) years. After adjusting for potential confounders, higher pre-pregnancy BMI was associated with an increased incidence of Caesarean-section (standardised b .011;p=.009 (95% CI .003,.019). Earlier gestation at delivery was strongly associated with need for NICU admission (standardised b -.087;p=<.001 (95% CI -.133,-.040), however GWG was not. GWG was not associated with rates of neonatal mortality, hypoglycaemia, birth trauma, jaundice or congenital abnormalities.
Conclusion: Although gestational weight gain was not associated with neonatal outcomes, a higher pre-pregnancy BMI was a significant predictor of Caesarean section in patients with pre-existing DM.